v3.26.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2026
Mar. 31, 2026
Dec. 31, 2025
Sep. 30, 2025
Mar. 31, 2025
Sep. 30, 2026
Sep. 30, 2025
Dec. 31, 2025
Cash flows provided by operating activities:                
Net income $ 122,130 $ 104,751   $ (284,183) $ 160,812 $ 299,463 $ 80,145  
Adjustments to reconcile net income to net cash provided by operating activities:                
Depreciation and amortization of intangible assets           275,520 292,706  
Goodwill impairment 0     364,248   0 364,248 $ 364,248
Impairment of non-financial assets 0     101,027   0 101,027  
Impairment of operating right-of-use assets and related property, plant and equipment           0 5,573  
Reduction in carrying value of operating right-of-use assets           34,596 29,473  
Share of net gains from equity method investments (16,298)     0   (16,298) 0  
Loss on disposal of subsidiary undertaking 0     0   32,947 0  
Amortization of financing costs 5,059     1,499   8,108 4,470  
Loss on extinguishment of debt 12,233     0   12,233 0  
Share-based compensation expense           63,319 72,529  
Deferred tax benefit           (32,986) (114,257)  
Unrealized foreign exchange movements           (24,963) 24,661  
Other non-cash items           4,195 20,561  
Changes in operating assets and liabilities:                
Accounts receivable           (99,754) (8,212)  
Unbilled revenue           64,474 (157,162)  
Unearned revenue           235,605 64,542  
Other net assets           (63,045) 21,739  
Net cash provided by operating activities           793,414 802,043  
Cash flows used in investing activities:                
Purchase of property, plant and equipment           (111,183) (114,885)  
Purchase of subsidiary undertakings (net of cash acquired)           0 (2,537)  
Cash outflow on disposal of subsidiary undertaking (including cash sold)           (57,142) 0  
Proceeds from investments in equity           2,908 2,114  
Purchase of investments in equity           (32,939) (16,286)  
Net cash used in investing activities           (198,356) (131,594)  
Cash flows used in financing activities:                
Debt issuance costs           (16,679) 0  
Early repayment fee           (7,841) 0  
Drawdown of credit lines and loan facilities           2,650,000 50,000  
Repayment of credit lines and loan facilities           (2,666,688) (72,321)  
Proceeds from shares issued under equity compensation plans           13,080 7,319  
Share issuance costs           (15) (14)  
Repurchase of ordinary shares           (400,000) (750,000)  
Share repurchase costs           (94) (450)  
Net cash used in financing activities           (428,237) (765,466)  
Effect of exchange rate movements on cash           (5,132) 25,120  
Net increase / (decrease) in cash and cash equivalents           161,689 (69,897)  
Cash and cash equivalents at beginning of period   $ 647,295 $ 468,888   $ 538,785 647,295 538,785 538,785
Cash and cash equivalents at end of period $ 808,984   $ 647,295 $ 468,888   $ 808,984 $ 468,888 $ 647,295